Impact of periprocedural pulmonary hypertension on outcomes after TAVR: novel risk stratification from the OCEAN-TAVI Registry

Back

ESC Professional Premium Access

Impact of periprocedural pulmonary hypertension on outcomes after TAVR: novel risk stratification from the OCEAN-TAVI Registry

Session: Transcatheter aortic valve implantation: trends, outcomes, and procedural considerations

Topic: Aortic Valve Intervention

Speaker: Mr J. Miyamoto (Kanagawa, JP)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Mr Junichi Miyamoto

Tokai University School of Medicine, Kanagawa (Japan)

0 follower

5 more presentations in this session

Trends in outcomes, complications and readmission rates in patients undergoing transcatheter aortic valve implantation: a nationwide analysis from 2012 to 2019

Speaker: Doctor A. Goel (Valhalla, US)

Hospital procedural volume and clinical outcomes for transcatheter aortic valve replacement - US nationwide readmission database, 2016-2019.

Speaker: Doctor O. Al-Taweel (Las Vegas, US)

Prevalence and prognostic impact of cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. AMY-TAVI study.

Speaker: Doctor D. Lopez Otero (Santiago de Compostela, ES)

Bioprosthetic valve fracture during valve-in-valve transcatheter aortic valve replacement: multicenter propensity matched analysis

Speaker: Doctor G. Bonnet (Bordeaux, FR)

Comparison of the safety and efficacy of antithrombotic regimens following TAVR in patients without having an indication for chronic oral anticoagulation

Speaker: Doctor P. Guedeney (Paris, FR)

Access the full session

Transcatheter aortic valve implantation: trends, outcomes, and procedural considerations

Speakers: Mr J. Miyamoto, Doctor A. Goel, Doctor O. Al-Taweel, Doctor D. Lopez Otero, Doctor G. Bonnet...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources